Individuals carrying homozygous susceptibility alleles of HLA-B*46:01, HLA-A*02:07, and heterozygous HLA-B*46:01/HLA-B*51:01 combination conferred ~3-fold higher risk of NPC (Supplementary Table 4). The gene discussed is HLA-B; the disease is nasopharyngeal carcinoma.